Pediatric Rheumatology

unofficial impact factor 1.74

This article is part of the supplement: 15th Paediatric Rheumatology European Society (PreS) Congress

Open Access

When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritis

FHM Prince*, M Twilt, SCM Simon, MAJ van Rossum, W Armbrust, EPAH Hoppenreijs, SSM Kamphuis, M van Santen-Hoeufft, Y Koopman-Keemink, N Wulffraat, R ten Cate and LWA van Suijlekom-Smit

  • * Corresponding author: FHM Prince

Pediatric Rheumatology 2008, 6(Suppl 1):P40 doi:10.1186/1546-0096-6-S1-P40

Accesses  

  • Last 30 days: 8 accesses
  • Last 365 days: 89 accesses
  • All time: 419 accesses